Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Quest Diagnostics ( DGX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.4%. By the end of trading, Quest Diagnostics rose $1.06 (1.8%) to $59.84 on average volume. Throughout the day, 3,347,922 shares of Quest Diagnostics exchanged hands as compared to its average daily volume of 2,573,300 shares. The stock ranged in a price between $58.72-$59.93 after having opened the day at $58.86 as compared to the previous trading day's close of $58.78. Other companies within the Health Services industry that increased today were: Biolase ( BIOL), up 10.9%, RadNet ( RDNT), up 9.8%, InspireMD ( NSPR), up 7.2% and Nanosphere ( NSPH), up 7.1%.

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. Quest Diagnostics has a market cap of $8.6 billion and is part of the health care sector. Shares are up 9.8% year to date as of the close of trading on Monday. Currently there are 2 analysts that rate Quest Diagnostics a buy, 4 analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Quest Diagnostics as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, notable return on equity, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Spectranetics Corporation ( SPNC), down 11.9%, IsoRay ( ISR), down 6.0%, Navidea Biopharmaceuticals ( NAVB), down 4.5% and ERBA Diagnostics ( ERB), down 4.3% , were all laggards within the health services industry with Boston Scientific Corporation ( BSX) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.